Pure Global

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes. - Trial NCT06382259

Access comprehensive clinical trial information for NCT06382259 through Pure Global AI's free database. This phase not specified trial is sponsored by University of British Columbia and is currently Recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06382259
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06382259
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.
The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes: a Randomized Controlled Crossover Trial

Study Focus

Type 2 Diabetes

Movement breaks

Interventional

other

Sponsor & Location

University of British Columbia

Kelowna, Canada

Timeline & Enrollment

N/A

Apr 25, 2024

Jul 15, 2025

30 participants

Primary Outcome

Mean 24-h glucose concentration assessed using continuous glucose monitoring assessed using continuous glucose monitoring

Summary

To conduct a randomized crossover trial to determine the acute impact of low-intensity
 movement breaks on glycemic control in physically inactive individuals living with type 2
 diabetes using continuous glucose monitoring.

ICD-10 Classifications

Type 2 diabetes mellitus
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT06382259

Non-Device Trial